Mustika, S.; Utami, S.; Saputri, N.E.W.; Poetri, L.N.; Awatara, P.I.D.; Rudijanto, A.; Purnomo, H.D.; Lesmana, C.R.A.; Taufiq, A.
Metabolic Dysfunction-Associated Steatotic Liver Disease: An Update Narrative Review of the Therapeutic Potential of Combining Probiotics and Metformin. Biomedicines 2026, 14, 1147.
https://doi.org/10.3390/biomedicines14051147
AMA Style
Mustika S, Utami S, Saputri NEW, Poetri LN, Awatara PID, Rudijanto A, Purnomo HD, Lesmana CRA, Taufiq A.
Metabolic Dysfunction-Associated Steatotic Liver Disease: An Update Narrative Review of the Therapeutic Potential of Combining Probiotics and Metformin. Biomedicines. 2026; 14(5):1147.
https://doi.org/10.3390/biomedicines14051147
Chicago/Turabian Style
Mustika, Syifa, Sri Utami, Nur Estu Wijayanti Saputri, Levrita Nindya Poetri, Putu Ijiya Danta Awatara, Achmad Rudijanto, Hery Djagat Purnomo, Cosmas Rinaldi A. Lesmana, and Ahmad Taufiq.
2026. "Metabolic Dysfunction-Associated Steatotic Liver Disease: An Update Narrative Review of the Therapeutic Potential of Combining Probiotics and Metformin" Biomedicines 14, no. 5: 1147.
https://doi.org/10.3390/biomedicines14051147
APA Style
Mustika, S., Utami, S., Saputri, N. E. W., Poetri, L. N., Awatara, P. I. D., Rudijanto, A., Purnomo, H. D., Lesmana, C. R. A., & Taufiq, A.
(2026). Metabolic Dysfunction-Associated Steatotic Liver Disease: An Update Narrative Review of the Therapeutic Potential of Combining Probiotics and Metformin. Biomedicines, 14(5), 1147.
https://doi.org/10.3390/biomedicines14051147
